Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Reprogramming and Venetoclax, with related work in Immunotherapy, Apoptosis, Prospective cohort study. Notable publications include 'Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature review', 'Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review', and 'Therapeutic efficacy of rare earth carbonate with chemoradiotherapy in late-stage non-small cell lung cancer: a cohort prospective study'.